Asymmetric dimethylarginine and angiogenesis: biological significance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Asymmetric dimethylarginine and angiogenesis: biological significance
Authors
Keywords
-
Journal
INTERNATIONAL ANGIOLOGY
Volume 37, Issue 6, Pages -
Publisher
Edizioni Minerva Medica
Online
2018-12-18
DOI
10.23736/s0392-9590.18.04017-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Higher serum asymmetric dimethylarginine is related to higher risk of heart failure in the EPIC-Potsdam study
- (2016) Janine Wirth et al. AMINO ACIDS
- Considerable impacts of AGXT2 V140I polymorphism on chronic heart failure in the Chinese population
- (2016) Xiao-Lei Hu et al. ATHEROSCLEROSIS
- Assessment of ADMA, estradiol, and progesterone in severe preeclampsia
- (2016) Jing-Jie Zheng et al. CLINICAL AND EXPERIMENTAL HYPERTENSION
- Dimethylarginine dimethylaminohydrolase-2 deficiency promotes vascular regeneration and attenuates pathological angiogenesis
- (2016) Clemens Lange et al. EXPERIMENTAL EYE RESEARCH
- Asymmetric Dimethylarginine Limits the Efficacy of Simvastatin Activating Endothelial Nitric Oxide Synthase
- (2016) Chiao‐Po Hsu et al. Journal of the American Heart Association
- CT-1 induces angiogenesis by regulating the ADMA/DDAH Pathway
- (2015) Zhen Zhong Zheng et al. BIOMEDICAL PAPERS-OLOMOUC
- Asymmetric Dimethyl-l-Arginine is a Biomarker for Disease Stage and Follow-Up of Pulmonary Hypertension Associated with Congenital Heart Disease
- (2015) Zhen-fei Fang et al. PEDIATRIC CARDIOLOGY
- Asymmetric Dimethylarginine and Progression of Chronic Kidney Disease - a One-Year Follow-Up Study
- (2014) Jaromír Eiselt et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Endothelial Dysfunction and Brachial Intima-Media Thickness: Long Term Cardiovascular Risk with Claudication Related to Peripheral Arterial Disease: A Prospective Analysis
- (2014) Franz Hafner et al. PLoS One
- Asymmetric dimethylarginine predicts decline of glucose tolerance in men with stable coronary artery disease: a 4.5-year follow-up study
- (2013) Andrzej Surdacki et al. Cardiovascular Diabetology
- DDAH1 Deficiency Attenuates Endothelial Cell Cycle Progression and Angiogenesis
- (2013) Ping Zhang et al. PLoS One
- Asymmetric Dimethyarginine as Marker and Mediator in Ischemic Stroke
- (2012) Shufen Chen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Exercise training increases endothelial progenitor cells and decreases asymmetric dimethylarginine in peripheral arterial disease: A randomized controlled trial
- (2011) Oliver Schlager et al. ATHEROSCLEROSIS
- In vivo nitric oxide synthesis, insulin sensitivity, and asymmetric dimethylarginine in obese subjects without and with metabolic syndrome
- (2011) Mario Siervo et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Elevated concentration of asymmetric dimethylarginine (ADMA) in individuals with metabolic syndrome
- (2011) Iván Palomo et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- The ADMA/DDAH Pathway Regulates VEGF-Mediated Angiogenesis
- (2009) Lorna R Fiedler et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- The DDAH/ADMA pathway in the control of endothelial cell migration and angiogenesis
- (2009) Lorna R. Fiedler et al. BIOCHEMICAL SOCIETY TRANSACTIONS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started